Recent Sarcoma News

Nexavar Improves Survival for Patients with Rare Sarcomas

(March 28, 2018)

Interim results from a randomized clinical trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF) show that the drug Nexavar (sorafenib tosylate) extended progression-free survival compared... Continue Reading